Part 2: Bile acids: microbial regulation of the gut-liver axis

This workshop will highlight the breadth of options available in the field of hepatology/liver transplant and provide practical guidance for trainees and early-career faculty. Session speakers will share perspectives on launching a successful career in ac

This session covers recently published data complemented by new guidance for clinical providers in recently finalized or published AASLD practice guidances. Attendees will learn about the diagnosis and treatment of patients with acute chronic liver failur

Part 2: Emerging humanized approaches to model liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major growing global disease. This symposium will address the variations in prevalence, diagnostic methods, and therapeutic options as it relates to MASLD, in different parts of the wor

Part 1: Portal Hypertension

With the projected deficit in hepatology providers identified by the Hepatology Workforce Study APPs are uniquely positioned to bridge the gap in access to hepatology care. This program will identify specific areas where APPs have an evolving impact.

This session covers the recent discoveries from studies in experimental cholestasis models and results of clinical trials targeting the gut-liver axis. Several investigations in patients with inflammatory cholestatic disease, i.e., PSC or biliary atresia,

The recent advances in the cellular and geospatial immuno-genomic heterogeneity of cholangiocarcinoma may impact the future therapeutic approaches for this malignancy. Attendees will review the current and emerging strategies to manage the disease (i.e.,

Part 2: Pushing the envelope in liver transplantation